Etiracetam
Etiracetam is a nootropic drug that is part of the racetam family. It is structurally similar to piracetam, the first nootropic drug of its kind, but with a higher potency. Etiracetam is known for its cognitive enhancing effects, particularly in the areas of memory, concentration, and mood.
History[edit]
Etiracetam was first synthesized in the 1970s as part of a series of compounds designed to improve cognitive function. It was developed by the same team that created piracetam, led by Dr. Corneliu E. Giurgea. The goal was to create a more potent version of piracetam, and etiracetam was one of the successful results.
Pharmacology[edit]
Like other racetams, etiracetam works by modulating the release of neurotransmitters in the brain. It is believed to enhance the function of the neurotransmitter acetylcholine, which plays a key role in memory and learning processes. It may also increase the density of acetylcholine receptors in the brain.
Clinical Use[edit]
Etiracetam is used in some countries as a prescription medication for conditions such as Alzheimer's disease, dementia, and other cognitive impairments. It is also used off-label by healthy individuals seeking to improve their cognitive performance.
Side Effects[edit]
Common side effects of etiracetam include headache, nausea, and irritability. These are usually mild and temporary. More serious side effects are rare, but can include allergic reactions and mood changes.
Legal Status[edit]
The legal status of etiracetam varies by country. In some countries, it is available as a prescription medication, while in others it is sold as a dietary supplement. In some jurisdictions, it is considered a controlled substance and is illegal to buy or sell without a prescription.
See Also[edit]
-
Etiracetam structure
-
Etiracetam 3D model
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
